Medical Condition News

RSS

Kira For Women introduces two new products for menopause, PMS

Natural women's health brand, Kira For Women, is launching two new products - Kira PMS Relief and Kira Menopause Relief.

25 Jan 2011

Study finds heart failure diagnosis four times higher in most economically disadvantaged communities

Heart failure diagnosis is four times higher in the most economically disadvantaged communities and twice as high among South Asians a new study at the University of Leicester has found.

25 Jan 2011

ASCO urges physicians, medical schools to improve quality of life for people with cancer

The American Society of Clinical Oncology today called on physicians, medical schools, insurers, and others to help improve quality of life for people with advanced cancer.

25 Jan 2011

Middle-aged women could reduce risk of cardiovascular disease by lowering blood pressure

Large numbers of middle-aged women worldwide could reduce their risk of developing cardiovascular disease (stroke, heart attack and heart failure) and its complications by lowering their blood pressure, researchers report in Hypertension: Journal of the American Heart Association.

25 Jan 2011

Majority of Americans unaware of law mandating equal coverage of mental health benefits

An overwhelming majority of Americans remain unaware of a law mandating equal coverage of mental health benefits by insurance companies, a cause for concern by psychologists at a time when one-quarter of Americans are reported to have a mental health disorder and only a minority are receiving treatment.

25 Jan 2011

UB's therapeutic program helps teens with ADHD to become better drivers

A University at Buffalo researcher's work with a state-of-the-art driving simulator is making better drivers among those considered to be the most risky motorists on the road: teens with ADHD.

25 Jan 2011

ASU Biodesign Institute hosts international research consortium on early detection of lung cancer

To address the latest issues on the early detection of lung cancer, the Biodesign Institute at Arizona State University will host an international research consortium in Scottsdale, Ariz., Feb. 25-26.

25 Jan 2011

Researchers show shunt operation can help patients with dementia

Researchers from the University of Gothenburg and Sahlgrenska University Hospital are the first in the world to show that an operation can help patients with dementia caused by white matter changes and hydrocephalus.

25 Jan 2011

American Heart Association: Cost of medical care for heart disease to raise in US by 2030

The cost to treat heart disease in the United States will triple by 2030, according to a policy statement published in Circulation: Journal of the American Heart Association.

25 Jan 2011

Study results of Pathwork Diagnostics's Tissue of Origin Test presented at ASCO 2011

Pathwork Diagnostics, Inc., a privately held molecular diagnostics company focused on oncology, announced today that results from a decision impact study of its Tissue of Origin Test were presented this weekend at the ASCO 2011 Gastrointestinal Cancers Symposium in San Francisco.

25 Jan 2011

Octapharma supports development of 'Diagnosis and Management of von Willebrand Disease' CE supplement

An unrestricted grant from Octapharma USA supported the development of a Continuing Education (CE) initiative entitled the "The Diagnosis and Management of von Willebrand Disease," a program of the National Home Infusion Association (NHIA).

25 Jan 2011

Sanofi-aventis acquires world-wide license for ADC products

Oxford BioTherapeutics today announces that sanofi-aventis has acquired an exclusive world-wide license to one of OBT's internal preclinical antibody programs.

25 Jan 2011

PharmaEngine presents PEP02 phase II studies in gastric and pancreatic cancers at ASCO 2011

PharmaEngine, Inc. announced today that two phase II studies of PEP02 (liposome irinotecan) in gastric and pancreatic cancer studies were presented at the 2011 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO) in San Francisco, CA, USA.

25 Jan 2011

Eisai to seek marketing authorization for perampanel in the U.S. and EU

Eisai announced today that it will submit Marketing Authorization Applications in the United States and the European Union for the investigational compound perampanel (E2007) based on the results of three Phase III pivotal studies. Perampanel is a first-in-class, highly selective non-competitive AMPA-type glutamate receptor antagonist, discovered and being developed by Eisai for adjunctive treatment of partial onset seizures in patients with epilepsy.

25 Jan 2011

New study on pain-relieving effect of transcutaneous Vagus Nerve Stimulation

The medical device company cerbomed cooperated with the Clinic for Psychiatry and Psychotherapy of the University of Regensburg 2010 on a randomized, controlled study into somatosensory pain processing. The study, lead by Prof. Dr. Peter Eichhammer and Dr. Volker Busch, aimed to judge the pain-relieving effect of transcutaneous Vagus Nerve Stimulation (t-VNS).

25 Jan 2011

New study: Workplace's key employees may experience high levels of job stress

A workplace's key employees may be at the greatest risk of experiencing high levels of work stress, according to a new study by the Centre for Addiction and Mental Health.

25 Jan 2011

Scientists to develop enzyme that protects against nerve agents

Protection against nerve gas attack is a significant component of the defense system of many countries around the world. Nerve gases are used by armies and terrorist organizations, and constitute a threat to both the military and civilian populations, but existing drug solutions against them have limited efficiency.

25 Jan 2011

Glioblastoma's molecular flexibility helps resist nearly all treatment efforts

Glioblastoma, the most common and lethal form of brain cancer and the disease that killed Massachusetts Senator Ted Kennedy, resists nearly all treatment efforts, even when attacked simultaneously on several fronts. One explanation can be found in the tumor cells' unexpected flexibility, discovered researchers at the Salk Institute for Biological Studies.

25 Jan 2011

Composer Fr-d-ric Chopin probably had temporal lobe epilepsy

The composer Fr-d-ric Chopin, who regularly hallucinated, probably had temporal lobe epilepsy throughout his short life, reveals research published online in Medical Humanities. Hallucinations typically feature in seizure disorders, they say.

25 Jan 2011

World's largest sterile compounding center for oncology patients

Health Robotics today announced the official opening and live operation of the largest Sterile Compounding Center for Oncology patients in the world. Akdeniz University Hospital in Antalya (Turkey) compounds 90% of its 80.000 annual chemotherapy intravenous doses with 4 CytoCare robots and related Health Robotics' technology, or an average of 325 patient doses per 6-hour work cycle.

25 Jan 2011

Medical Condition News

Kira For Women introduces two new products for menopause, PMS

Study finds heart failure diagnosis four times higher in most economically disadvantaged communities

ASCO urges physicians, medical schools to improve quality of life for people with cancer

Middle-aged women could reduce risk of cardiovascular disease by lowering blood pressure

Majority of Americans unaware of law mandating equal coverage of mental health benefits

UB's therapeutic program helps teens with ADHD to become better drivers

ASU Biodesign Institute hosts international research consortium on early detection of lung cancer

Researchers show shunt operation can help patients with dementia

American Heart Association: Cost of medical care for heart disease to raise in US by 2030

Study results of Pathwork Diagnostics's Tissue of Origin Test presented at ASCO 2011

Octapharma supports development of 'Diagnosis and Management of von Willebrand Disease' CE supplement

Sanofi-aventis acquires world-wide license for ADC products

PharmaEngine presents PEP02 phase II studies in gastric and pancreatic cancers at ASCO 2011

Eisai to seek marketing authorization for perampanel in the U.S. and EU

New study on pain-relieving effect of transcutaneous Vagus Nerve Stimulation

New study: Workplace's key employees may experience high levels of job stress

Scientists to develop enzyme that protects against nerve agents

Glioblastoma's molecular flexibility helps resist nearly all treatment efforts

Composer Fr-d-ric Chopin probably had temporal lobe epilepsy

World's largest sterile compounding center for oncology patients

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Latest News